Literature DB >> 9709713

Month-to-month variability of lipids, lipoproteins, and apolipoproteins and the impact of acute infection in adolescents.

S S Gidding1, N J Stone, L C Bookstein, P M Laskarzewski, E A Stein.   

Abstract

OBJECTIVE: To assess month-to-month variability of total cholesterol, triglycerides, high-density lipoprotein-cholesterol (HDL-C), calculated low-density lipoprotein-cholesterol (LDL-C), apolipoprotein A1, apolipoprotein B, and lipoprotein (a), as well as factors that could influence variability, including recent acute infection in an adolescent population.
METHODS: Sixty-three high school students had fasting lipids and lipoproteins measured at 4 separate times during the school year and another venipuncture 3 to 7 days after recovery from an acute infection. Erythrocyte sedimentation rate was also measured. Coefficients of variation were calculated for each study variable. The influence of recent infection on variability was assessed.
RESULTS: The 50th and 95th percentiles, respectively, for the coefficient of variation for each variable were as follows: total cholesterol, 7.3% and 13.6%; triglycerides, 22% and 47.3%; HDL-C, 7.9% and 16.8%; LDL-C, 12.1% and 25%; apolipoprotein A1, 6.3% and 15.2%; apolipoprotein B, 9.5% and 17.2%; and lipoprotein (a), 19.3% and 40%. Recent infection significantly lowered HDL-C (4 mg/dL; P < .0001) and apolipoprotein A1 (7 mg/dL; P < .005).
CONCLUSIONS: Clinicians evaluating lipids and lipoproteins serially should expect significant visit-to-visit variation in triglycerides and calculated LDL-C values. Assessment of HDL-C and apolipoprotein A1 should not be done within 2 weeks of an acute infection. Apolipoproteins B and A1 have slightly less variability than their respective lipoprotein cholesterol values (LDL-C and HDL-C).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9709713     DOI: 10.1016/s0022-3476(98)70227-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

1.  A pilot study identifying statin nonadherence with visit-to-visit variability of low-density lipoprotein cholesterol.

Authors:  Devin M Mann; Nicole L Glazer; Michael Winter; Michael K Paasche-Orlow; Paul Muntner; Daichi Shimbo; William G Adams; Nancy R Kressin; Yuqing Zhang; Hyon Choi; Howard Cabral
Journal:  Am J Cardiol       Date:  2013-02-20       Impact factor: 2.778

2.  Post-transcriptional nature of uremia-induced downregulation of hepatic apolipoprotein A-I production.

Authors:  Hamid Moradi; Hamid M Said; Nosratola D Vaziri
Journal:  Transl Res       Date:  2012-12-03       Impact factor: 7.012

Review 3.  New insights into the mechanism of low high-density lipoprotein cholesterol in obesity.

Authors:  Hao Wang; Dao-Quan Peng
Journal:  Lipids Health Dis       Date:  2011-10-12       Impact factor: 3.876

4.  Are non-high-density lipoprotein fractions associated with pediatric metabolic syndrome? The CASPIAN-V study.

Authors:  Pooneh Angoorani; Majid Khademian; Hanieh-Sadat Ejtahed; Ramin Heshmat; Mohammad Esmaeil Motlagh; Mahya Vafaeenia; Gita Shafiee; Armita Mahdivi-Gorabi; Mostafa Qorbani; Roya Kelishadi
Journal:  Lipids Health Dis       Date:  2018-11-14       Impact factor: 3.876

Review 5.  Hyperhomocysteinemia, Suppressed Immunity, and Altered Oxidative Metabolism Caused by Pathogenic Microbes in Atherosclerosis and Dementia.

Authors:  Kilmer S McCully
Journal:  Front Aging Neurosci       Date:  2017-10-06       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.